Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Active ingredients: bupivacaine + adrenaline (epinephrine)
What it is used for
Pfizer Bupivacaine with adrenaline injection is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows;,Surgical anaesthesia:,- Epidural block for surgery,- Field block (minor and major nerve blocks and infiltration),Analgesia,- Continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain,- Field block (minor nerve block and infiltration),The choice of 2 strengths, 0.25%, and 0.5% makes it possible to vary the degree of motor blockade.
How to take it
The way to take this medicine is: Subcutaneous. This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.
- Store below 25 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 18 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Clear, colourless or almost colourless solution, practically free from visible particles
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
ASCIA Guidelines Acute management of anaphylaxis - Australasian Society of Clinical Immunology and Allergy (ASCIA)
ASCIA Acute Management of Anaphylaxis Guidelines
Read more on ASCIA – Australasian Society of Clinical Immunology and Allergy website
The challenge of costly drugs | Issue 3 | Volume 39 | Australian Prescriber
The Pharmaceutical Benefits Scheme costs Australia over $9 billion. Are taxpayers receiving value for money? Read about the challenges of providing uniform...
Read more on Australian Prescriber website